ReachMD
Be part of the knowledge.™Public Profile
Affiliations
University of Colorado Denver School of Medicine
DisclosuresDr. Zeitler is or has served as a consultant for AstraZeneca LP, Bristol-Myers-Squibb Company, Daiichi-Sankyo, Merck/Schering-Plough Pharmaceuticals; and is or has received research support from Eli Lilly and Company.
Dr. Philip Zeitler is professor of pediatrics and clinical science and director of the pediatric endocrinology training program at the University of Colorado Denver School of Medicine. He is also medical director of the Children's Hospital Clinical Translational Research Center of the Colorado Clinical Translational Science Institute. He is attending endocrinologist at The Children's Hospital and the Barbara Davis Center for Childhood Diabetes, where he is director of the Type 2 diabetes and metabolic syndrome programs.
Dr. Zeitler currently serves as study chair of TODAY, a national, NIH-funded, multi-center trial examining treatment options for adolescents with type 2 diabetes, as well as the TODAY Genetics Study, a national effort to establish a DNA sample bank of individuals with onset of type 2 diabetes prior to age 18.